|
|
Post by sportsrancho on Sept 8, 2017 11:42:02 GMT -5
|
|
|
|
Post by navpoon on Sept 8, 2017 11:54:48 GMT -5
Mannkind will need to free up cash as well....if Ray doesn't fit into the mold of their future then this is the right move. Usually when new management comes in they make changes to executives. Mike knows what he is doing and I trust this is a result of his future direction.
|
|
|
|
Post by babaoriley on Sept 8, 2017 12:22:57 GMT -5
Mannkind is going to have to sell something or dilute unfortunately. Maybe they are holding off on that until they see the label change text, maybe not. They would be foolish to sell TS in its entirety though Whether it's a single product (TREP-T) or a class of applications that are licensed out (oncology), I think an actual sale would be very beneficial for the company in the short-mid term. Sell TS, extend the runway plenty and retain a small royalty (which could be worth a whole lot in ten years, if TS becomes the hit we've all thought since about 100 years ago). |
|
|
|
Post by sportsrancho on Sept 8, 2017 12:48:14 GMT -5
Mannkind is going to have to sell something or dilute unfortunately. Maybe they are holding off on that until they see the label change text, maybe not. They would be foolish to sell TS in its entirety though Whether it's a single product (TREP-T) or a class of applications that are licensed out (oncology), I think an actual sale would be very beneficial for the company in the short-mid term. Sell TS, extend the runway plenty and retain a small royalty (which could be worth a whole lot in ten years, if TS becomes the hit we've all thought since about 100 years ago). And if Mike does do that it points to Afrezza having real blockbuster potential! IMO he's got this:-) |
|
|
|
Post by agedhippie on Sept 8, 2017 19:46:53 GMT -5
Sell TS, extend the runway plenty and retain a small royalty (which could be worth a whole lot in ten years, if TS becomes the hit we've all thought since about 100 years ago). And if Mike does do that it points to Afrezza having real blockbuster potential! IMO he's got this:-) I think it's the right thing to do (not that I expect my endorsement to make any difference to Mike  ). At this point the if Afrezza fails then TS is irrelevant so the best option is to buy the maximum runway possible for Afrezza and if that means selling TS then do it. |
|
|
|
Post by akemp3000 on Sept 8, 2017 20:06:14 GMT -5
Last month, Mike discussed multiple options that could be used to extend the runway. Selling TS wasn't one of them and is frankly a ridiculous suggestion.
|
|
|
|
Post by falconquest on Sept 8, 2017 21:24:27 GMT -5
Quite frankly my jury is still out on Mike. I think he has brought some good ideas to Mannkind but the proof is in the pudding (sales) which I have harped on for a long time now. Until he proves himself as more than a can kicker then my jury remains in recess. .....and I don't care what the stock price does.
|
|
|
|
Post by uvula on Sept 8, 2017 22:20:21 GMT -5
Last month, Mike discussed multiple options that could be used to extend the runway. Selling TS wasn't one of them and is frankly a ridiculous suggestion. Can you please explain why you feel this way? I personally think they should do what ever it takes to save afrezza. Do you think TS is too valuable to sell? What else can they do to raise money? |
|
|
|
Post by promann on Sept 8, 2017 22:35:50 GMT -5
I think it's very strange that they don't even mention MNKD at all in his expieriance, it's as if they don't want to speak of little ol MannKind. |
|
|
|
Post by lakon on Sept 8, 2017 22:49:26 GMT -5
Last month, Mike discussed multiple options that could be used to extend the runway. Selling TS wasn't one of them and is frankly a ridiculous suggestion. Can you please explain why you feel this way? I personally think they should do what ever it takes to save afrezza. Do you think TS is too valuable to sell? What else can they do to raise money? I feel the same way. You don't throw the baby out with the bath water. TS is the baby. Afrezza is the grand child... Besides, nobody wants TS until after its successful. Afrezza is the only way to prove it successful at the moment. They have a lot of other options, already discussed elsewhere. I hate to say it, but BK and restructuring is always an option. Nobody would want TS at that point either so they could try it again Sam after restructuring... |
|
|
|
Post by rockstarrick on Sept 8, 2017 22:51:21 GMT -5
Last month, Mike discussed multiple options that could be used to extend the runway. Selling TS wasn't one of them and is frankly a ridiculous suggestion. Can you please explain why you feel this way? I personally think they should do what ever it takes to save afrezza. Do you think TS is too valuable to sell? What else can they do to raise money? Technosphere is an FDA approved Drug Delivery Method that if/when Inhalation is deemed superior to Injections, could be the goose that continually lays Golden Eggs. I believe Mannkind will lease the process for Royalties, I certainly hope they don't outright sell it. in my opinion, TS is untouchable. Time will tell. |
|
|
|
Post by mango on Sept 8, 2017 23:27:54 GMT -5
|
|
|
|
Post by akemp3000 on Sept 9, 2017 1:28:27 GMT -5
To add... Al Mann formed MNKD as a biotech "developmental" company, not a drug "manufacturing" company. Today's website describes Mannkind as "a bio pharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases". The company exists because of TS. When SNY failed to bring Afrezza to market, the company was forced to go it alone and had to become a manufacturing and commercialization company in part...at least until such time Afrezza is hugely successful at which time the company could either sell it for a ton of money or remain a manufacturer in part. If MNKD were to sell TS, it would immediately become a pure manufacturing and commercialization company with nothing left to develop. This was never Al's or the company's vision nor has it ever been discussed publicly as an option by anyone in MNKD management. The future and upside potential of MNKD is TS. Afrezza just happened to be the first and most challenging TS application. IMHO, the only way TS might be sold would be if a new owner purchased the company outright. Management, under all three CEO's, has always been clear that the company is going to build its value first. Commercialization has been a struggle but the company exists because it owns the TS goose that has the potential to lay countless golden eggs. Ray Urbanski's departure may simply be because his primary expertise is with only one of the TS applications, oncology, and he's a better fit with an oncology driven company.
|
|
|
|
Post by uvula on Sept 9, 2017 6:46:23 GMT -5
Sometimes things don't go according to plan. No one ever imagined that we would be in the position we are in right now.
Some people say we can't sell TS because it is too valuable. Others say we can't sell TS because no one wants to buy it. The only thing we all agree on is that we can't sell TS. (Quite frankly we are having trouble selling Afrezza also.)
When we all seem to agree on something the opposite thing happens.
|
|
|
|
Post by sportsrancho on Sept 9, 2017 7:30:50 GMT -5
Does anyone know for sure that Ray left MNKD? I'm not.
|
|
). At this point the if Afrezza fails then TS is irrelevant so the best option is to buy the maximum runway possible for Afrezza and if that means selling TS then do it.
